B-VITAMINS AND DIABETIC NEPHROPATHY 26 Sha'ban 1431 (H) Equal 7 August 2010 (G)The Journal of the American Medical Association published a randomized controlled trial on April 28, 2010 that found the administration of B-vitamins failed to slow the progression of diabetic nephropathy and was associated with an increase in vascular events. The trial was stopped early for safety reasons.1..more
Saudi Food and Drug Authority (SFDA) PRESS RELEASE – Safety of Angiotensin-receptor blockers (ARBs) 07 Sha'ban 1431 (H) Equal 19 July 2010 (G)Recently, some newspapers have published articles that have unnecessarily frightened patients with high blood pressure taking a group of medications called Angiotensin-receptor blockers (ARBs) and a possible link with the development of cancer..more
Revision and Updating of Prescribing Information for Tramadol Containing Products 21 Rajab 1431 (H) Equal 3 July 2010 (G)The Saudi Food and Drug Authority (SFDA) notifies healthcare professionals of changes to the Warnings section of the prescribing information for tramadol, a centrally acting synthetic opioid analgesic indicated for the management of moderate to moderately severe ..more
Safety Review of GnRH Agonists and possible increased risk of diabetes and certain cardiovascular diseases 21 Rajab 1431 (H) Equal 3 July 2010 (G)The Saudi Food and Drug Authority (SFDA) is evaluating whether Gonadotropin-Releasing Hormone (GnRH) Agonists may increase the risk of diabetes and certain cardiovascular diseases (heart attack, sudden cardiac death, stroke) in men receiving these medications for the treatment ..more
Safety Review of Proton Pump Inhibitors and Possible Increased Risk of Fracture of the Hip, Wrist, and Spine 16 Rajab 1431 (H) Equal 28 June 2010 (G)The Saudi Food and Drug Authority (SFDA) has revised the labels for a class of drugs known as proton pump inhibitors (PPIs) to include new safety information about a possible increased risk of fractures of the hip, wrist, and spine with the use of these medications at higher doses or long duration..more